Literature DB >> 12187274

The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder.

R A Harvey1, D E Skennerton, D Newgreen, C H Fry.   

Abstract

PURPOSE: We compared the potency of adenosine triphosphate (ATP) and its nonhydrolyzable analogue alpha,beta-methylene ATP for generating contractions in human detrusor smooth muscle from patients with a stable, unstable and obstructed bladders. The different ATP potencies were compared with the ecto-adenosine triphosphatase (ATPase) of these samples.
MATERIALS AND METHODS: Contractile experiments were done in vitro by superfusing samples with purines and dose-response curves were generated. Ecto-ATPase activity was measured from the rate of ATP hydrolysis sensitive to the ecto-ATPase inhibitor ARL 67156 with a luciferin-luciferase assay.
RESULTS: ATP generated contractions with a mean EC50 of 933 microM. in tissue from stable bladders and was significantly more potent in tissue from unstable and obstructed bladders (EC50 141 and 172 microM., respectively). alpha,beta-methylene ATP was more potent in tissue from stable and unstable bladders (mean combined EC50 3 microM.). In guinea pig detrusor the mean EC50 for ATP and alpha,beta-methylene ATP was 138 and 5.5 microM., respectively. Mean total ATPase activity in unstable bladder biopsies plus or minus standard deviation was about 50% of that in stable bladder biopsies (2.54 +/- 1.50 versus 1.37 +/- 0.46 nmol. per second per mg. protein ). The ARL 67156 sensitive fraction was also significantly less in samples from unstable compared with stable bladders (mean 0.94 +/- 0.41 versus 0.36 +/- 0.26 nmol. per second mg. protein ).
CONCLUSIONS: The greater potency of ATP for generating contractions in detrusor from unstable bladders may be due to reduced extracellular hydrolysis, allowing purine greater access to detrusor smooth muscle. This finding may explain atropine resistant purine based contractions in detrusor from unstable bladders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12187274     DOI: 10.1097/01.ju.0000024391.74486.f1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

Review 1.  How does the urothelium affect bladder function in health and disease? ICI-RS 2011.

Authors:  L A Birder; M Ruggieri; M Takeda; G van Koeveringe; S Veltkamp; C Korstanje; B Parsons; C H Fry
Journal:  Neurourol Urodyn       Date:  2012-01-24       Impact factor: 2.696

Review 2.  Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.

Authors:  Donna Sellers; Russ Chess-Williams; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

3.  Aging differentially modifies agonist-evoked mouse detrusor contraction and calcium signals.

Authors:  Pedro J Gomez-Pinilla; Maria J Pozo; Pedro J Camello
Journal:  Age (Dordr)       Date:  2010-07-03

4.  Post- and prejunctional consequences of ecto-ATPase inhibition: electrical and contractile studies in guinea-pig vas deferens.

Authors:  P Ghildyal; D Palani; R Manchanda
Journal:  J Physiol       Date:  2006-05-04       Impact factor: 5.182

5.  A commonly used ecto-ATPase inhibitor, ARL-67156, blocks degradation of ADP more than the degradation of ATP in murine colon.

Authors:  L Durnin; N Moreland; A Lees; V N Mutafova-Yambolieva
Journal:  Neurogastroenterol Motil       Date:  2016-04-05       Impact factor: 3.598

6.  The elusive electromyogram in the overactive bladder: a spark of understanding.

Authors:  Andrew Ballaro
Journal:  Ann R Coll Surg Engl       Date:  2008-07       Impact factor: 1.891

7.  Early life voiding dysfunction leads to lower urinary tract dysfunction through alteration of muscarinic and purinergic signaling in the bladder.

Authors:  Nao Iguchi; Anna P Malykhina; Duncan T Wilcox
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-08

Review 8.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 9.  Purinoceptors as therapeutic targets for lower urinary tract dysfunction.

Authors:  Anthony P D W Ford; Joel R Gever; Philip A Nunn; Yu Zhong; Joseph S Cefalu; Michael P Dillon; Debra A Cockayne
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

10.  Impairment of ATP hydrolysis decreases adenosine A1 receptor tonus favoring cholinergic nerve hyperactivity in the obstructed human urinary bladder.

Authors:  M Silva-Ramos; I Silva; M Faria; M T Magalhães-Cardoso; J Correia; F Ferreirinha; P Correia-de-Sá
Journal:  Purinergic Signal       Date:  2015-10-31       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.